To date, two studies have reported that soluble B7-H4 (sB7-H4) expression is upregulated in the serum of patients with HCC and that high levels of sB7-H4 are associated with an advanced clinical tumor stage13,14. The gene discussed is VTCN1; the disease is neoplasm.